Medicare utilization — DR. SCOTT J MCKNIGHT (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 134,400 | 87 | $0 | $68,596 |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 12,780 | 64 | $0 | $366,183 |
| 92134 | Imaging of retina | 1,030 | 711 | $0 | $28,502 |
| J2778 | Injection, ranibizumab, 0.1 mg | 955 | 60 | $0 | $172,363 |
| 92014 | Established patient complete exam of visual system | 483 | 482 | $0 | $39,147 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·